{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:58:24Z","timestamp":1790949504712,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T00:00:00Z","timestamp":1475107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T00:00:00Z","timestamp":1475107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Numerous studies have investigated the utility of serum intestinal fatty-acid binding protein (I-FABP) in differentiating acute intestinal ischemia from acute abdomen. However, the results remain controversial. The aim of this meta-analysis is to determine the overall accuracy of serum I-FABP in the diagnosis of acute intestinal ischemia. Publications addressing the accuracy of serum I-FABP in the diagnosis of ischemic bowel diseases were selected from databases. The values of true-positive (TP), true-negative (TN), false-positive (FP) and false-negative (FN) were extracted or calculated for each study. Pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR) and diagnostic odds ratio (DOR) were calculated. The overall diagnostic performance was assessed using a summary receiver operating characteristic curve (SROC) and area under curve (AUC). Nine studies that collectively included 1246 patients met the eligible criteria. The pooled sensitivity, specificity, DOR, PLR and NLR were 0.80 (95% CI: 0.72\u20130.86), 0.85 (95% CI: 0.73\u20130.93), 24 (95% CI: 9\u201365), 5.5 (95% CI: 2.8\u201310.8) and 0.23 (95% CI: 0.15\u20130.35), respectively. The AUC was 0.86 (95% CI: 0.83\u20130.89). The meta-analysis carried out in this report suggests that the I-FABP may be a useful diagnostic tool to confirm acute intestinal ischemia in acute abdomen, but better-designed trials are still required to confirm our findings.<\/jats:p>","DOI":"10.1038\/srep34371","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T09:56:05Z","timestamp":1475142965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Accuracy of the serum intestinal fatty-acid-binding protein for diagnosis of acute intestinal ischemia: a meta-analysis"],"prefix":"10.1038","volume":"6","author":[{"given":"Da-Li","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Yun","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,29]]},"reference":[{"key":"BFsrep34371_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/j.semvascsurg.2009.12.001","volume":"23","author":"S Acosta","year":"2010","unstructured":"Acosta, S. Epidemiology of mesenteric vascular disease: clinical implications. Semin Vasc Surg 23, 4\u20138 (2010).","journal-title":"Semin Vasc Surg"},{"key":"BFsrep34371_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1148\/radiol.10091938","volume":"256","author":"J Menke","year":"2010","unstructured":"Menke, J. Diagnostic accuracy of multidetector CT in acute mesenteric ischemia: systematic review and meta-analysis. Radiology 256, 93\u2013101 (2010).","journal-title":"Radiology"},{"key":"BFsrep34371_CR3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2214\/AJR.08.1138","volume":"192","author":"A Furukawa","year":"2009","unstructured":"Furukawa, A. et al. CT diagnosis of acute mesenteric ischemia from various causes. AJR Am J Roentgenol 192, 408\u2013416 (2009).","journal-title":"AJR Am J Roentgenol"},{"key":"BFsrep34371_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejrad.2003.11.013","volume":"50","author":"G Angelelli","year":"2004","unstructured":"Angelelli, G. et al. Acute bowel ischemia: CT findings. Eur J Radiol 50, 37\u201347 (2004).","journal-title":"Eur J Radiol"},{"key":"BFsrep34371_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2036.2005.02269.x","volume":"21","author":"PL Kozuch","year":"2005","unstructured":"Kozuch, P. L. et al. Review article: diagnosis and management of mesenteric ischemia with an emphasis on pharmacotherapy. Aliment Pharmacol Ther 21, 201\u2013215 (2005).","journal-title":"Aliment Pharmacol Ther"},{"key":"BFsrep34371_CR6","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s00268-009-0074-7","volume":"33","author":"NJ Evennett","year":"2009","unstructured":"Evennett, N. J. et al. Systematic review and pooled estimates for the diagnostic accuracy of serological markers for intestinal ischemia. World J Surg 33, 1374\u20131383 (2009).","journal-title":"World J Surg"},{"key":"BFsrep34371_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.clnu.2008.02.005","volume":"27","author":"P Crenn","year":"2008","unstructured":"Crenn, P. et al. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 27, 328\u2013339 (2008).","journal-title":"Clin Nutr"},{"key":"BFsrep34371_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3402\/ljm.v8i0.20596","volume":"8","author":"R Cakmaz","year":"2013","unstructured":"Cakmaz, R. et al. A combination of plasma DAO and citrulline levels as a potential marker for acute mesenteric ischemia. Libyan J Med 8, 1\u20136 (2013).","journal-title":"Libyan J Med"},{"key":"BFsrep34371_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0009-9120(03)00096-1","volume":"36","author":"MM Pelsers","year":"2003","unstructured":"Pelsers, M. M. et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem 36, 529\u2013535 (2003).","journal-title":"Clin Biochem"},{"key":"BFsrep34371_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.clinre.2014.12.005","volume":"39","author":"H Shi","year":"2015","unstructured":"Shi, H. et al. The role of serum intestinal fatty acid binding protein levels and D-lactate levels in the diagnosis of acute intestinal ischemia. Clin Res Hepatol Gastroenterol 39, 373\u2013378 (2015).","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"BFsrep34371_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/bjs.9331","volume":"101","author":"S Matsumoto","year":"2014","unstructured":"Matsumoto, S. et al. Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia. BJS 101, 232\u2013238 (2014).","journal-title":"BJS"},{"key":"BFsrep34371_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s00535-011-0373-2","volume":"46","author":"T Kanda","year":"2011","unstructured":"Kanda, T. et al. Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation study. J Gastroenterol 46, 492\u2013500 (2011).","journal-title":"J Gastroenterol"},{"key":"BFsrep34371_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/SLA.0b013e318207a767","volume":"253","author":"G Thuijls","year":"2011","unstructured":"Thuijls, G. et al. Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins. Ann Surg 253, 302\u2013308 (2011).","journal-title":"Ann Surg"},{"key":"BFsrep34371_CR14","doi-asserted-by":"publisher","first-page":"e99915","DOI":"10.1371\/journal.pone.0099915","volume":"13","author":"H Kittaka","year":"2014","unstructured":"Kittaka, H. et al. Usefulness of intestinal fatty acid-binding protein in predicting strangulated small bowel obstruction. PLoS One 13, e99915 (2014).","journal-title":"PLoS One"},{"key":"BFsrep34371_CR15","first-page":"531","volume":"30","author":"H Jin","year":"2014","unstructured":"Jin, H. Value of intestinal fatty acid binding protein in diagnose of ischemic bowel disease. Chin J Immuno (Chinese) 30, 531\u2013533 (2014).","journal-title":"Chin J Immuno (Chinese)"},{"key":"BFsrep34371_CR16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.cursur.2006.05.006","volume":"63","author":"DR Cronk","year":"2006","unstructured":"Cronk, D. R. et al. Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg 63, 322\u2013325 (2006).","journal-title":"Curr Surg"},{"key":"BFsrep34371_CR17","first-page":"690","volume":"51","author":"H Shi","year":"2012","unstructured":"Shi, H. et al. The value of serum intestinal fatty acid blinding protein measurement in discriminating intestinal ischemia in patients with acute abdomen. Chin J Intern Med (Chinese) 51, 690\u2013693 (2012).","journal-title":"Chin J Intern Med (Chinese)"},{"key":"BFsrep34371_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/MEG.0b013e32832183a7","volume":"21","author":"PB Mensink","year":"2009","unstructured":"Mensink, P. B. et al. Transient postprandial ischemia is associated with increased intestinal fatty acid binding protein in patients with chronic gastrointestinal ischemia. Eur J Gastroenterol Hepatol 21, 278\u2013282 (2009).","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BFsrep34371_CR19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1097\/SLA.0b013e31824b1e16","volume":"255","author":"IC Vermeulen Windsant","year":"2012","unstructured":"Vermeulen Windsant, I. C. et al. Circulating intestinal fatty acid-binding protein as an early marker of intestinal necrosis after aortic surgery: a prospective observational cohort study. Ann Surg 255, 796\u2013803 (2012).","journal-title":"Ann Surg"},{"key":"BFsrep34371_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-2253-14-111","volume":"14","author":"PH van der Voort","year":"2014","unstructured":"van der Voort, P. H. et al. Can serum L-lactate, D-lactate, creatine kinase and I-FABP be used as diagnostic markers in critically ill patients suspected for bowel ischemia. BMC Anesthesiol 14, 111 (2014).","journal-title":"BMC Anesthesiol"},{"key":"BFsrep34371_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.7326\/0003-4819-149-12-200812160-00008","volume":"149","author":"MM Leeflang","year":"2008","unstructured":"Leeflang, M. M. et al. Systematic reviews of diagnostic test accuracy. Ann Intern Med 149, 889\u2013897 (2008).","journal-title":"Ann Intern Med"},{"key":"BFsrep34371_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-3-25","volume":"3","author":"P Whiting","year":"2003","unstructured":"Whiting, P. et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3, 25 (2003).","journal-title":"BMC Med Res Methodol"},{"key":"BFsrep34371_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijcard.2009.05.063","volume":"140","author":"CM Jones","year":"2010","unstructured":"Jones, C. M. et al. Diagnostic accuracy meta-analysis: a review of the basic principles of interpretation and application. Int J Cardiol 140, 138\u2013144 (2010).","journal-title":"Int J Cardiol"},{"key":"BFsrep34371_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins, J. P. et al. Measuring inconsistency in meta-analyses. BMJ 327, 557\u2013560 (2003).","journal-title":"BMJ"},{"key":"BFsrep34371_CR25","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","volume":"58","author":"JJ Deeks","year":"2005","unstructured":"Deeks, J. J. et al. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58, 882\u2013893 (2005).","journal-title":"J Clin Epidemiol"},{"key":"BFsrep34371_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/00365510701646264","volume":"68","author":"T Block","year":"2008","unstructured":"Block, T. et al. Diagnostic accuracy of plasma biomarkers for intestinal ischaemia. Scand J Clin Lab Invest 68, 242\u2013248 (2008).","journal-title":"Scand J Clin Lab Invest"},{"key":"BFsrep34371_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1053\/gast.1996.v110.pm8566578","volume":"110","author":"T Kanda","year":"1996","unstructured":"Kanda, T. et al. Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 110, 339\u2013343 (1996).","journal-title":"Gastroenterology"},{"key":"BFsrep34371_CR28","first-page":"95","volume":"9","author":"KQ Hu","year":"2010","unstructured":"Hu, K. Q. et al. Change of plasma intestinal fatty acid-binding protein and liver fatty acid-binding protein in children with intestinal ischemia. J Clin Pedia Surg (Chinese) 9, 95\u201397 (2010).","journal-title":"J Clin Pedia Surg (Chinese)"},{"key":"BFsrep34371_CR29","first-page":"418","volume":"39","author":"KQ Hu","year":"2010","unstructured":"Hu, K. Q. et al. The value of serum intestinal fatty acid blinding protein measurement in discriminating intestinal ischemia in children. Shanxi Med J (Chinese) 39, 418\u2013419 (2010).","journal-title":"Shanxi Med J (Chinese)"},{"key":"BFsrep34371_CR30","first-page":"624","volume":"19","author":"WL Yan","year":"2013","unstructured":"Yan, W. L. et al. Diagnostic value of plasma intestinal fatty acid-binding protein and creatine kinase in patients subjected with intestinal obstruction. Zhongguo Zhong Xi Yi Jie He Za Zhi (Chinese) 19, 624\u2013626 (2013).","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi (Chinese)"},{"key":"BFsrep34371_CR31","first-page":"64","volume":"1","author":"L Li","year":"2012","unstructured":"Li, L. & Liang, H. F. Application of IFABP, LFABP detection technology in children with intestinal ischemia. Chin J Pharma Econom (Chinese) 1, 64\u201366 (2012).","journal-title":"Chin J Pharma Econom (Chinese)"},{"key":"BFsrep34371_CR32","first-page":"371","volume":"16","author":"H Jin","year":"2014","unstructured":"Jin, H. The relationship between intestinal fatty acid binding protein and the severity and prognosis of ischemic bowel disease. Zhe Jiang Lin Chuang Yi Xue (Chinese) 16, 371\u2013372 (2014).","journal-title":"Zhe Jiang Lin Chuang Yi Xue (Chinese)"},{"key":"BFsrep34371_CR33","first-page":"2535","volume":"21","author":"DH Shen","year":"2005","unstructured":"Shen, D. H. et al. The value of serum intestinal fatty acid blinding protein in intestinal diseases. Shi Yong Yi Xue Za Zhi (Chinese) 21, 2535\u20132536 (2005).","journal-title":"Shi Yong Yi Xue Za Zhi (Chinese)"},{"key":"BFsrep34371_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s10620-010-1303-5","volume":"56","author":"D van Noord","year":"2011","unstructured":"van Noord, D. et al. Serum markers and intestinal mucosal injury in chronic gastrointestinal ischemia. Dig Dis Sci 56, 506\u2013512 (2011).","journal-title":"Dig Dis Sci"},{"key":"BFsrep34371_CR35","first-page":"144","volume":"7","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. The diagnosis value of combination of I-FABP, D-LAC, Fg in acute ischemic enteritis. Lin Chuang He Li Yong Yao (Chinese) 7, 144\u2013145 (2014).","journal-title":"Lin Chuang He Li Yong Yao (Chinese)"},{"key":"BFsrep34371_CR36","first-page":"410","volume":"35","author":"L Zheng","year":"2014","unstructured":"Zheng, L. et al. The value of I-FABP measurement in the diagnosis of intestinal ischemic in patients with acute intestinal obstruction. Int J Lab Med (Chinese) 35, 410\u2013411 (2014).","journal-title":"Int J Lab Med (Chinese)"},{"key":"BFsrep34371_CR37","first-page":"112","volume":"7","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. The diagnosing value of I-FABP, D-LAC in ischemic enteritis. Lin Chuang He Li Yong Yao (Chinese) 7, 112\u2013114 (2014).","journal-title":"Lin Chuang He Li Yong Yao (Chinese)"},{"key":"BFsrep34371_CR38","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1128\/JCM.01371-10","volume":"48","author":"M Riffelmann","year":"2010","unstructured":"Riffelmann, M. et al. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol 48, 4459\u20134463 (2010).","journal-title":"J Clin Microbiol"},{"key":"BFsrep34371_CR39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/jcm.34.1.94-97.1996","volume":"34","author":"BA van de Wouw","year":"1996","unstructured":"van de Wouw, B. A. et al. Comparison of three commercially available enzyme-linked immunosorbent assays and biopsy-dependentdiagnosis for detecting Helicobacter pylori infection. J Clin Microbiol 34(1), 94\u201397 (1996).","journal-title":"J Clin Microbiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep34371","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T22:06:18Z","timestamp":1672869978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep34371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,29]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,14]]}},"alternative-id":["BFsrep34371"],"URL":"https:\/\/doi.org\/10.1038\/srep34371","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,29]]},"assertion":[{"value":"1 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34371"}}